Cnsl | List of Frontiers open access articles

Original Research

Published on 10 Aug 2022

Prognostic significance of CNSL at diagnosis of childhood B-cell acute lymphoblastic leukemia: A report from the South China Children’s Leukemia Group

in Hematologic Malignancies

Lu-Hong Xu
Xu Geng
Ning Liao
Li-Hua Yang
Hui-Rong Mai
Wu-Qing Wan
Li-Bin Huang
Min-Cui Zheng
Chuan Tian
Hui-Qin Chen

Frontiers in Oncology

doi 10.3389/fonc.2022.943761

4,363 views
9 citations

Original Research

Published on 23 Nov 2021

Evaluation of Carbon Nanoparticle Suspension and Methylene Blue Localization for Preoperative Localization of Nonpalpable Breast Lesions: A Comparative Study

in Surgical Oncology

Yeqing Zhou
Yiran Liang
Jianshu Zhang
Yang Feng
Xiaoyan Li
Xiaoli Kong
Tingting Ma
Liyu Jiang
Qifeng Yang

Frontiers in Surgery

doi 10.3389/fsurg.2021.757694

4,327 views
8 citations

Original Research

Published on 26 Mar 2021

CXCL13 and CXCL9 CSF Levels in Central Nervous System Lymphoma—Diagnostic, Therapeutic, and Prognostic Relevance

in Neuro-Oncology and Neurosurgical Oncology

Ilias Masouris
Kirsi Manz
Markus Pfirrmann
Martin Dreyling
Barbara Angele
Andreas Straube
Sigrid Langer
Marion Huber
Uwe Koedel
Louisa Von Baumgarten

Frontiers in Neurology

doi 10.3389/fneur.2021.654543

5,167 views
24 citations

Original Research

Published on 13 Jan 2026

CAR-T cell therapy in TP53-mutated CNS lymphoma: overcoming a high-risk genetic barrier

in Gene and Cell Therapy

Danyang Li
Rui Liu
Zhonghua Fu
Fan Yang
Lixia Ma
Miaomiao Cao
Yuelu Guo
Biping Deng
Alex H. Chang
Qinlong Zheng

Frontiers in Medicine

doi 10.3389/fmed.2025.1731589

1,084 views

Systematic Review

Published on 01 Jul 2021

Efficacy and Safety of Ibrutinib in Central Nervous System Lymphoma: A PRISMA-Compliant Single-Arm Meta-Analysis

in Hematologic Malignancies

Liwei Lv
Xuefei Sun
Yuchen Wu
Qu Cui
Yuedan Chen
Yuanbo Liu

Frontiers in Oncology

doi 10.3389/fonc.2021.707285

11,558 views
22 citations

Systematic Review

Published on 24 Jan 2024

Sustained efficacy of chimeric antigen receptor T-cell therapy in central nervous system lymphoma: a systematic review and meta-analysis of individual data

in Pharmacology of Anti-Cancer Drugs

Jing Zhou
Zhenhao Wang
Hanyu Wang
Yang Cao
Gaoxiang Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1331844

3,682 views
5 citations

Original Research

Published on 03 Nov 2025

Relapsed or refractory central nervous system lymphoma successfully treated by glofitamab combined with lenalidomide

in Hematologic Malignancies

Yin-yin Peng
Xiao-qiong Tang

Frontiers in Oncology

doi 10.3389/fonc.2025.1685271

2,476 views
1 citation

Case Report

Published on 31 Jan 2023

Double systemic cytokine release syndrome following sequential infusion of anti-CD22 and anti-CD19 chimeric antigen receptor T cells after autologous hematopoietic stem cell transplantation for a central diffuse large B-cell lymphoma patient: A case report and literature review

in Cancer Immunity and Immunotherapy

Jing Zheng
Yao Xiao
Xue Q. Wu
Qiong Z. Xiao
Chun Feng
Kai B. Gao

Frontiers in Immunology

doi 10.3389/fimmu.2023.1098815

6,575 views
4 citations

Original Research

Published on 19 Aug 2022

Efficacy and safety of CD19-specific CAR-T cell-based therapy in secondary central nervous system lymphoma

in Cancer Immunity and Immunotherapy

Huanxin Zhang
Zhiling Yan
Ying Wang
Yuekun Qi
Yongxian Hu
Ping Li
Jiang Cao
Meng Zhang
Xia Xiao
Ming Shi

Frontiers in Immunology

doi 10.3389/fimmu.2022.965224

6,781 views
9 citations

Case Report

Published on 23 Jan 2024

Sequential autologous CAR-T and allogeneic CAR-T therapy successfully treats central nervous system involvement relapsed/refractory ALL: a case report and literature review

in Hematologic Malignancies

Yifan Liu
Yanfen Li
Zhangyu Yu
Rongrong Wang
Yu Jing

Frontiers in Oncology

doi 10.3389/fonc.2024.1341682

3,922 views
1 citation

Systematic Review

Published on 23 Mar 2026

Safety and efficacy of CAR T-cell therapy in central nervous system lymphoma: a systematic review and meta-analysis

in Cancer Immunity and Immunotherapy

Ahmad E. Shawabkeh
Jehad Yasin
Muaath I. Alsufi
Homam S. AbuHashesh
Hebah Khraisat
Zaid Muhanna
Izere Salomon
Salma A. Salman
Ahmad Obeid
Layan AlDaher

Frontiers in Oncology

doi 10.3389/fonc.2026.1790444

1,108 views

Articles

Prognostic significance of CNSL at diagnosis of childhood B-cell acute lymphoblastic leukemia: A report from the South China Children’s Leukemia Group

Evaluation of Carbon Nanoparticle Suspension and Methylene Blue Localization for Preoperative Localization of Nonpalpable Breast Lesions: A Comparative Study

CXCL13 and CXCL9 CSF Levels in Central Nervous System Lymphoma—Diagnostic, Therapeutic, and Prognostic Relevance

CAR-T cell therapy in TP53-mutated CNS lymphoma: overcoming a high-risk genetic barrier

Efficacy and Safety of Ibrutinib in Central Nervous System Lymphoma: A PRISMA-Compliant Single-Arm Meta-Analysis

Sustained efficacy of chimeric antigen receptor T-cell therapy in central nervous system lymphoma: a systematic review and meta-analysis of individual data

Relapsed or refractory central nervous system lymphoma successfully treated by glofitamab combined with lenalidomide

Double systemic cytokine release syndrome following sequential infusion of anti-CD22 and anti-CD19 chimeric antigen receptor T cells after autologous hematopoietic stem cell transplantation for a central diffuse large B-cell lymphoma patient: A case report and literature review

Efficacy and safety of CD19-specific CAR-T cell-based therapy in secondary central nervous system lymphoma

Sequential autologous CAR-T and allogeneic CAR-T therapy successfully treats central nervous system involvement relapsed/refractory ALL: a case report and literature review

Safety and efficacy of CAR T-cell therapy in central nervous system lymphoma: a systematic review and meta-analysis